| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,906 | 1,080 | 17:13 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | Q-linea AB Q3 Loss Declines | 1 | RTTNews | ||
| 30.10. | Q-Linea AB: Interim Report January 1 - September 30 2026 | 146 | GlobeNewswire (Europe) | US moving forward on expanded ASTar® panel
Third quarter 2026 (July - September)• Contracted ASTar instruments 3 (5)• Net sales MSEK 4.8 (3.5)• Consumables sales per instrument (R12) TSEK 247 (306)•... ► Artikel lesen | |
| 20.08. | Q-Linea AB: Q-linea appoints Malin Svensson as new Chief Financial Officer | 647 | GlobeNewswire (Europe) | Q-linea AB (publ) today announces that Malin Svensson has been appointed Chief Financial Officer and Investor Relations manager. She will assume her position no later than January 1, 2027
Malin Svensson... ► Artikel lesen | |
| 18.08. | Q-Linea AB: Q-linea awarded a contract position with Premier, Inc. | 1.098 | GlobeNewswire (Europe) | Q-linea AB (publ) has been awarded a contract position with national group purchasing organization, Premier, Inc.
Effective September 1, 2026, the new agreement allows the over 4,000 Premier member... ► Artikel lesen | |
| 10.08. | Q-Linea AB: Q-linea Announces ASTar Contract With Large Health System in the U.S. Mid-Atlantic Region | 886 | GlobeNewswire (Europe) | Q-linea AB (publ) announces today that it has signed a contract with a major U.S. health system in the mid-Atlantic region for deployment of its ASTar® rapid antimicrobial susceptibility testing (AST)... ► Artikel lesen | |
| 10.07. | Q-Linea AB: Interim report January 1 - June 30 2026 | 1.220 | GlobeNewswire (Europe) | FDA decision sets up for growth in U.S. FDA clearance for expanded U.S. menu combined with encouraging progress across Europe and focus organisation, positions Q-linea for growth during the second half... ► Artikel lesen | |
| Q-LINEA Aktie jetzt für 0€ handeln | |||||
| 29.05. | Q-Linea AB: Annika Blondeau Henriksson new interim CFO | 579 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces that the company has hired Annika Blondeau Henriksson as CFO and IR. Annika takes office on June 15, 2026, when she succeeds Christer Samuelsson, who... ► Artikel lesen | |
| 27.05. | Q-linea AB: Bulletin From Annual General Meeting In Q-linea AB (publ) | 390 | GlobeNewswire (Europe) | The annual general meeting of Q-linea AB (publ) (the "Company"), reg. no. 556729-0217, was held on 27 May 2026 in Uppsala, at which the shareholders mainly passed the following resolutions. All resolutions... ► Artikel lesen | |
| 30.04. | Q-Linea AB: Interim report January - March 2026 | 461 | GlobeNewswire (Europe) | Growing recurring income and increased market activity within rapid AST
First quarter: 1 January-31 March 2026Income from sales of consumables amounted to SEK 1.4 (0.9) million, an increase of approx.... ► Artikel lesen | |
| 16.04. | Q-Linea AB: Q-linea announces FDA clearance of expanded ASTar blood testing menu | 673 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces the company has received 510(k) clearance from the US FDA for its expanded ASTar® Gram-negative Blood Culture menu.
The expanded panel represents a significant... ► Artikel lesen | |
| 30.12.25 | Q-Linea AB: Q-linea signs first distribution agreement in South Asia | 548 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA today announces the signing of its first distribution agreement in South Asia, marking an important milestone in the company's global expansion strategy. The agreement... ► Artikel lesen | |
| 23.12.25 | Q-Linea AB: Q-linea announces first two US hospital systems' clinical implementation of ASTar | 314 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces the clinical implementation of the first US ASTar instruments at UI (University of Iowa) Health Care and a large healthcare system in Texas. UI Health Care... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 51,55 | -0,44 % | Fresenius gewinnt eine neue Wachstumsstory | Fresenius hat den schwierigen Teil seiner Neuaufstellung offenbar weitgehend hinter sich gelassen. Der Gesundheitskonzern steigert seine Profitabilität, reduziert die finanzielle Belastung und hebt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,060 | -0,62 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 27 auf 26 Euro gekappt und die Aktien von "Equal Weight" auf "Underweight" abgestuft. Dem... ► Artikel lesen | |
| INTUITIVE SURGICAL | 368,40 | -0,69 % | INTUITIVE SURGICAL INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| DRAEGERWERK | 117,20 | +1,21 % | Ihre wichtigsten Termine: Heute im Fokus: Target, Drägerwerk, Oracle, TJX, Lowe's, Bullish und Novartis | © Foto: Eibner-Pressefoto/Ardan Fuessman - Eibner-PressefotoGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag... ► Artikel lesen | |
| MEDTRONIC | 92,70 | +1,09 % | Medtronic: What Happens When Healthcare Technology Starts With People | From living rooms to operating rooms, human-centered design is informing the future of tech?Key takeawaysHuman-centered design at Medtronic uses patient, caregiver, and clinician insights to make medical... ► Artikel lesen | |
| THERMO FISHER | 621,00 | -1,08 % | 65% der untersuchten FDA-Rückschläge betrafen Produktionsstätten: Die unsichtbare Hürde für Lonza, Thermo Fisher und NeuroThera | ||
| TELADOC HEALTH | 6,986 | -1,77 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| HIMS & HERS HEALTH | 14,000 | -4,11 % | Hims & Hers Health, Inc: Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss | Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss
New YouGov research finds 61% of UK women are trying to lose weight, yet many are working... ► Artikel lesen | |
| M1 AESTHETICS | 13,500 | +1,50 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,059 | 0,00 % | Sernova Biotherapeutics: 11,2 Millionen Dollar für die Fusion - und doch rutscht die Aktie | ||
| ALCON | 67,92 | -0,67 % | 1,8 Milliarden Menschen mit Alterssichtigkeit: Warum Alcon und EssilorLuxottica neue Sehlösungen entwickeln | ||
| DEXCOM | 72,80 | -0,55 % | DexCom, Inc.: Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone | Opening ceremony attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Minister for Enterprise, Tourism and Employment, Peter... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,230 | -1,35 % | Siemens Healthineers Aktie: Zwischen Übergangsjahr und Kursfantasie | Die Analysten sind sich nach den jüngsten Quartalszahlen von Siemens Healthineers uneinig über die weiteren Perspektiven der Aktie. Während Jefferies nach der Erholung im Geschäft mit medizinischer... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,56 | -0,67 % | BMO raises BrightSpring Health stock price target on LDD momentum |